We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Drugs of Abuse: Trends and Advanced Analytical Methods

    Abuse of drugs is correlated with various medical, behavioral, psychological, spiritual, financial, social, family, and legal concerns and profoundly...
    Chapter 2023
  2. Abuse of Performance-Enhancing Drugs

    Anabolic-androgen steroids (AASs) are the primary drug class in a larger pattern of drug use designed to improve one’s appearance or alter their...
    Reference work entry 2022
  3. Influence of Sex on the Effects of Nicotine and Other Drugs of Abuse on Intracranial Self-Stimulation

    Drug abuse is one of the leading causes of loss of productivity, disease, and early death in the world. People typically start experimenting with...
    Ranjithkumar Chellian, Ryann Wilson, ... Adriaan W. Bruijnzeel in Methods for Preclinical Research in Addiction
    Protocol 2022
  4. A Chewing Study of Abuse-Deterrent Tablets Containing Polyethylene Oxide Using a Robotic Simulator

    Abuse-deterrent formulations (ADFs) refer to formulation technologies aiming to deter the abuse of prescription drugs by making the dosage forms...

    Bangxiang Chen, Feng Zhang, ... Weiliang Xu in AAPS PharmSciTech
    Article 29 November 2023
  5. Drugs of Abuse Affecting 5-HT2B Receptors

    Stimulant and psychedelic drugs of abuse exert their effects through interactions with monoaminergic systems. Compared to other monoaminergic...
    Dino Luethi, Matthias E. Liechti in 5-HT2B Receptors
    Chapter 2021
  6. Effect of Stanozolol and/or Cannabis Abuse on Hypertrophic Mechanism and Oxidative Stress of Male Albino Rat Cardiac Tissue in Relation to Exercise: A Sport Abuse Practice

    Adolescents commonly co-abuse many drugs including anabolic androgenic steroids either they are athletes or non-athletes. Stanozolol is the major...

    Noha A. Mowaad, Rania Elgohary, Shaimaa ElShebiney in Cardiovascular Toxicology
    Article Open access 08 May 2024
  7. The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act

    Rationale

    Lemborexant (LEM) is a dual orexin receptor antagonist (DORA) approved in multiple countries including the USA, Japan, Canada, Australia,...

    Margaret Moline, Shoji Asakura, ... Jack E. Henningfield in Psychopharmacology
    Article Open access 07 February 2023
  8. Androgen Abuse

    Reference work entry 2024
  9. Opioid abuse and SIV infection in non-human primates

    Human immunodeficiency virus (HIV) and drug abuse are intertwined epidemics, leading to compromised adherence to combined antiretroviral therapy...

    Uma Maheswari Deshetty, Sudipta Ray, ... Palsamy Periyasamy in Journal of NeuroVirology
    Article 07 July 2023
  10. Solvent Abuse

    Reference work entry 2024
  11. Influence of Social Defeat Stress on the Rewarding Effects of Drugs of Abuse

    Drug addiction is a serious problem in our society. Some individuals develop dependence to different substances very accessible in the market, mainly...
    María Pilar García-Pardo, José Enrique De la Rubia-Ortí, ... María A. Aguilar in Methods for Preclinical Research in Addiction
    Protocol 2022
  12. Substance abuse and neurodegenerative diseases: focus on ferroptosis

    Psychostimulants and alcohol are widely abused substances with the adverse effects on global public health. Substance abuse seriously harms people's...

    Cheng Guo, Lei Chen, Yun Wang in Archives of Toxicology
    Article 26 April 2023
  13. Design of Abuse-Deterrent Formulations Using Various Types of Thermal Deformed Starch (TDS)

    Purpose

    In recent years, the problem of drug abuse has emerged and is becoming more serious. Drug abuse can be secretly and illegally perpetuated by...

    Jeong Sun Sohn, Jin-Seok Choi in Journal of Pharmaceutical Innovation
    Article 05 June 2023
  14. Abusive Drugs

    Reference work entry 2024
  15. Quantification of 108 illicit drugs and metabolites in bile matrix by LC–MS/MS for the toxicological testing of sudden death cases

    Sudden death could occur after assumption of illicit drugs for recreational purposes in adults or after intoxication in children, and toxicological...

    Martina Franzin, Rachele Ruoso, ... Riccardo Addobbati in Archives of Toxicology
    Article Open access 05 December 2023
  16. The imidazoline I2 receptor agonist 2-BFI reduces abuse-related effects of morphine: self-administration and drug discrimination

    Rationale

    Increasing evidence shows that imidazoline I 2 receptor agonists enhance opioid-induced analgesia, suggesting that the combination of I 2 ...

    Justin N. Siemian, Kristen Woodhouse, ... Jun-Xu Li in Psychopharmacology
    Article 30 December 2023
  17. A consideration of CYP2D6 genetic variations in the Ghanaian population as a potential ‘culprit’ for the tramadol ‘abuse crisis’

    Background

    Cytochrome P450 2D6 is involved in the metabolism of several important medicines including opioids. Variations in CYP2D6 have been...

    Nicholas Ekow Thomford, Susanna Aba Abraham, ... Robert Peter Biney in BMC Medical Genomics
    Article Open access 22 January 2024
  18. Abuse and dependence potential of sphingosine-1-phosphate (S1P) receptor modulators used in the treatment of multiple sclerosis: a review of literature and public data

    Abuse and misuse of prescription drugs remains an ongoing concern in the USA and worldwide; thus, all centrally active new drugs must be assessed for...

    Kerri A. Schoedel, Carine Kolly, ... Kasra Shakeri-Nejad in Psychopharmacology
    Article Open access 13 November 2021
  19. Abuse, dependence and withdrawal associated with fentanyl and the role of its (designated) route of administration: an analysis of spontaneous reports from Europe

    Purpose

    Fentanyl, a highly potent synthetic opioid used in cancer and non-cancer pain, is approved for various routes of administration. In Europe,...

    Kathrin Jobski, Carsten Bantel, Falk Hoffmann in European Journal of Clinical Pharmacology
    Article Open access 16 December 2022
Did you find what you were looking for? Share feedback.